ELUTIA INC. - CLASS A COMMON STOCK
3.7900
04-أكتوبر-24 15:59:56
15 متأخرة بدقائق
الأسهم
-0.0200
-0.52%
نطاق اليوم
3.7000 - 3.8500
ISIN
N/A
المصدر
NASDAQ
-
18 سبتمبر 2024 08:00:00 بحسب Nasdaq GlobeNewswire
-
06 سبتمبر 2024 16:23:52 بحسب Nasdaq GlobeNewswire
-
05 سبتمبر 2024 16:05:00 بحسب Nasdaq GlobeNewswire
-
Elutia to Participate in Upcoming Investor Conferences
03 سبتمبر 2024 16:05:00 بحسب Nasdaq GlobeNewswire
-
Elutia Announces Second Quarter 2024 Results
07 أغسطس 2024 16:05:01 بحسب Nasdaq GlobeNewswire
-
Elutia Announces Full Exercise of Warrants Generating $15.7 Million in Gross Proceeds
01 أغسطس 2024 16:05:00 بحسب Nasdaq GlobeNewswire
-
Elutia Appoints Ryan Marques, Ph.D., MBA as Vice President of Operations
31 يوليو 2024 16:05:00 بحسب Nasdaq GlobeNewswire
-
Elutia to Report Second Quarter 2024 Financial Results on Wednesday, August 7, 2024
30 يوليو 2024 16:05:00 بحسب Nasdaq GlobeNewswire
-
Elutia to Present at the Emerging Growth Conference on Thursday, July 18
11 يوليو 2024 16:05:00 بحسب Nasdaq GlobeNewswire
-
Elutia Announces $13.26 Million Registered Direct Offering
17 يونيو 2024 08:01:00 بحسب Nasdaq GlobeNewswire
-
17 يونيو 2024 08:00:00 بحسب Nasdaq GlobeNewswire
-
Elutia to Showcase BioEnvelope Product Line at Heart Rhythm 2024
13 مايو 2024 08:00:00 بحسب Nasdaq GlobeNewswire
-
09 مايو 2024 16:05:01 بحسب Nasdaq GlobeNewswire
-
Elutia to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024
02 مايو 2024 16:05:00 بحسب Nasdaq GlobeNewswire
-
Elutia to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1
24 أبريل 2024 16:05:00 بحسب Nasdaq GlobeNewswire
-
Elutia to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 7, 2024
22 فبراير 2024 16:05:00 بحسب Nasdaq GlobeNewswire
-
Elutia Regains Compliance with Nasdaq Listing Requirements
10 يناير 2024 16:05:00 بحسب Nasdaq GlobeNewswire
-
Elutia Submits CanGarooRM® Antibiotic-Eluting Biomatrix for FDA Clearance
18 ديسمبر 2023 08:00:00 بحسب Nasdaq GlobeNewswire
-
13 نوفمبر 2023 16:05:01 بحسب Nasdaq GlobeNewswire
-
Elutia Completes Divestiture of Orthobiologics Business Unit for Cash Proceeds of Up to $35 Million
09 نوفمبر 2023 08:30:00 بحسب Nasdaq GlobeNewswire
- <<
- <
- 1
- >